Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.verified

TERN

Price:

$8.23

Market Cap:

$532.29M

Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical trial for the treatment of NASH; and TERN-201, a vascular adhesion protein-1 inhibitor that is in Phase Ib clinical trial for the treatment of NASH. It also develops TERN-501, a thyroid hormone receptor beta agonist with enhanced liver distribution and metabolic stability that is in Phase I clinical trial for the treatment of NASH; and TERN-601, a smal...[Read more]

Industry

Biotechnology

IPO Date

2021-02-05

Stock Exchange

NASDAQ

Ticker

TERN

The Enterprise Value as of June 2024 (TTM) for Terns Pharmaceuticals, Inc. (TERN) is 467.62M

According to Terns Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 467.62M. This represents a change of 8.70% compared to the average of 430.19M of the last 4 quarters.

Terns Pharmaceuticals, Inc. (TERN) Historical Enterprise Value (quarterly & annually)

How has TERN Enterprise Value performed in the past?

The mean historical Enterprise Value of Terns Pharmaceuticals, Inc. over the last ten years is 324.41M. The current 467.62M Enterprise Value has changed 14.31% with respect to the historical average. Over the past ten years (40 quarters), TERN's Enterprise Value was at its highest in in the March 2023 quarter at 642.86M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

324.41M

Median

370.73M

Minimum

130.95M

Maximum

449.20M

Terns Pharmaceuticals, Inc. (TERN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Terns Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 71.65%

Maximum Annual Enterprise Value = 449.20M

Minimum Annual Increase = -67.27%

Minimum Annual Enterprise Value = 130.95M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023383.15M70.45%
2022224.79M71.65%
2021130.95M-67.27%
2020400.08M-10.94%
2019449.20M25.36%

Terns Pharmaceuticals, Inc. (TERN) Average Enterprise Value

How has TERN Enterprise Value performed in the past?

The current Enterprise Value of Terns Pharmaceuticals, Inc. (TERN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

246.30M

5-year avg

317.63M

10-year avg

324.41M

Terns Pharmaceuticals, Inc. (TERN) Enterprise Value vs. Peers

How is TERN’s Enterprise Value compared to its peers?

Terns Pharmaceuticals, Inc.’s Enterprise Value is greater than Amylyx Pharmaceuticals, Inc. (-55328570.00), greater than Acumen Pharmaceuticals, Inc. (139.86M), greater than Inozyme Pharma, Inc. (316.12M), greater than X4 Pharmaceuticals, Inc. (164.24M), less than Mereo BioPharma Group plc (554.21M), greater than PDS Biotechnology Corporation (58.34M), greater than HOOKIPA Pharma Inc. (-15916720.00), less than Day One Biopharmaceuticals, Inc. (834.52M), greater than Eledon Pharmaceuticals, Inc. (108.22M),

Build a custom stock screener for Terns Pharmaceuticals, Inc. (TERN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Terns Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Terns Pharmaceuticals, Inc. (TERN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Terns Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Terns Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?

What is the 3-year average Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?

What is the 5-year average Enterprise Value for Terns Pharmaceuticals, Inc. (TERN)?

How does the current Enterprise Value for Terns Pharmaceuticals, Inc. (TERN) compare to its historical average?